References
- Jefferson T, Demicheli V, Deeks J, et al. Neuraminidase inhibitors for preventing and treating influenza in healthy adults. Cochrane Database Syst Rev. 2000;2:CD001265.
- Doshi P. Neuraminidase inhibitors-the story behind the Cochrane review. BMJ. 2009;339:b5164.
- Loder E, Tovey D, Godlee F. The Tamiflu trials. BMJ. 2014;348:g2630.
- Jefferson T, Doshi P. Multisystem failure: the story of anti-influenza drugs. BMJ. 2014;348:g2263.
- Krumholz HM. Neuraminidase inhibitors for influenza. BMJ. 2014;348:g2548.
- Dryad data. Available from: http://dx.doi.org/10.5061/dryad.77471 [last accessed 5 May 2016].
- Tamiflu, Relenza, and influenza: what the data do (or don’t) tell us? Dryad Data 2014; [Internet]. Available from: https://blog.datadryad.org/2014/04/17/tamiflu-data/ [last accessed 5 May 2016].
- Muthuri SG, Venkatesan S, Myles PR, et al. Effectiveness of neuraminidase inhibitors in reducing mortality in patients admitted to hospital with influenza A H1N1pdm09 virus infection: a meta-analysis of individual participant data. Lancet Respir Med. 2014;2:395–404.
- Muthuri SG, Venkatesan S, Myles PR, et al. Impact of neuraminidase inhibitors on influenza A(H1N1) pdm09-related pneumonia: an IPD meta-analysis. Influenza Other Respir Viruses. 2016;10:192–204.
- Dobson J, Whitley RJ, Pocock S, et al. Oseltamivir treatment for influenza in adults: a meta-analysis of randomised controlled trials. Lancet. 2015;385:1729–1737.
- Kelly H, Cowling BJ. Influenza: the rational use of oseltamivir. Lancet. 2015;385:1700–1702.
- Dunn AG, Arachi D, Hudgins J, et al. Financial conflicts of interest and conclusions about neuraminidase inhibitors for influenza: an analysis of systematic reviews. Ann Intern Med. 2014;161:513–518.
- Transcript for CDC Telebriefing: update on Flu Season 2014-15 [Internet]. Available from: http://www.cdc.gov/media/releases/2015/t0108-fluupdate.html [last accessed 5 May 2016].